Sacituzumab Tirumotecan Combined With Immunotherapy in Advanced Thyroid Cancer
Sacituzumab Tirumotecan Combined With Immunotherapy in Advanced Thyroid Cancer
Recruiting · NCT07068542 · Registry updated 2026-06-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Sacituzumab Tirumotecan Combined With Immunotherapy in Advanced Thyroid Cancer | Neoplasms by Histologic Type, carcinoma, epithelial neoplasm, neoplasm, poorly differentiated thyroid gland carcinoma, thyroid gland undifferentiated (anaplastic) carcinoma | Recruiting | Not applicable | 2026-06-01 | NCT07068542 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Zhejiang Provincial People's Hospital | 74 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Zhejiang Provincial People's Hospital | Hangzhou | China | 48 |